NCT07739667 Blood Pressure Measurement Using Vitacam
| NCT ID | NCT07739667 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Evondos Oy |
| Condition | Blood Pressure Measurement |
| Study Type | OBSERVATIONAL |
| Enrollment | 85 participants |
| Start Date | 2026-05-11 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 85 participants in total. It began in 2026-05-11 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this clinical investigation is to collect data for the development, testing, and validation of a blood pressure measurement algorithm for a contactless vital signs monitor, Vitacam, according to the ISO 80601-2:2019 standard for validating non-invasive sphygmomanometer, with the intention of disseminating the validation results through a peer-reviewed scientific publication.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Ability to give informed consent * Volunteering for the study * Fluent Finnish or English Exclusion Criteria: * Age under 18 years * Pregnancy * Inability to give informed consent * Denial
Contact & Investigator
Antti Vehkaoja
PRINCIPAL INVESTIGATOR
Tampere University
Frequently Asked Questions
Who can join the NCT07739667 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure Measurement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07739667 currently recruiting?
Yes, NCT07739667 is actively recruiting participants. Contact the research team at moyeen.ahmad@evondos.com for enrollment information.
Where is the NCT07739667 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT07739667 clinical trial?
NCT07739667 is sponsored by Evondos Oy. The principal investigator is Antti Vehkaoja at Tampere University. The trial plans to enroll 85 participants.